Schedule 13D ownership disclosure
IKENA ONCOLOGY INC
Common Stock, par value $0.001 per share · CUSIP: 45175G108
Event date: 2025-06-16
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- BML Investment Partners, L.P.Reported CIK 0001373604
Shares: 4,030,102 · Class: 8.35%
- Leonard Braden MichaelReported CIK 0001373603
Shares: 4,090,102 · Class: 8.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001373604-25-000088
- Form type
- SCHEDULE 13D
- Filer
- BML Investment Partners, L.P.
- CIK
- CIK 1373604
- Filed
- Jun 16, 2025
- Reporting period
- Jun 16, 2025
- Description
- Schedule 13D beneficial ownership